Warburg Pincus bags CMO biz with JHP buy; eyes B+L sale
Private equity group Warburg Pincus has acquired sterile injectables specialist JHP Pharmaceuticals for $195m and says it has a “sizable amount” to invest in the CMO.
Private equity group Warburg Pincus has acquired sterile injectables specialist JHP Pharmaceuticals for $195m and says it has a “sizable amount” to invest in the CMO.
API maker BioVectra has been acquired by autoimmune disease focused drugmaker Questcor Pharmaceuticals for C$50m.
An oral solid dose manufacturing plant operated by Kemwell has passed an inspection by the US Food and Drug Administration (FDA).
Australian CRO Clinical Network Services (CNS) has positioned itself as a “truly regional solution” with the acquisition of New Zealand-based Beltas.
Saltigo says climbing raw materials, energy and shipping costs prompted it to increase the price of key chemical intermediates, 1,2,4-triazole and chloroformate.
Synteract will add trial capacity in Europe, Israel and South America through the acquisition of Munich-based Harrison Clinical Research. (HCR).